Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

61 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Sildenafil for the Treatment of Lymphatic Malformations

NCT02335242

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, +3 more
Locations
  • Stanford University Stanford, California, United States
  • University of Colorado, Denver Aurora, Colorado, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details
Completed

A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)

NCT01667133

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +16 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Akita University Hospital Akita, Japan
  • Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital Hiroshima, Japan
  • Kyushu University Hospital Hukuoka-shi, Hukuoka, Japan
View Trial Details
Completed

Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30+ PTCL Patients

NCT02497131

Conditions
Hemic and Lymphatic Diseases, Lymphatic Diseases
Locations
  • Ematologia "L. & A. Seragnoli" - Policlinico S. Orsola Malpighi Bologna, Italy
  • Ematologia e Trapianto IRCCS, Istituto Nazionale dei Tumori Milan, Italy
  • SC Ematologia - Città della Salute e della Scienza Torino, Italy
  • A.O. Universitaria S. Maria Della Misericordia Di Udine Udine, Italy
View Trial Details
Completed

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

NCT02265731

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +30 more
Locations
  • NHO Nagoya Medical Center /ID# 129222 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 129061 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 129278 Nagoya, Aichi-ken, Japan
  • University of Fukui Hospital /ID# 165801 Yoshida-gun, Fukui, Japan
View all 14 locations
View Trial Details
Completed

Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease

NCT02416661

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +16 more
Locations
  • University Hospital Center Mother Teresa Tirana, Albania
  • Aristotle University of Thessaloniki, Ippokration General Hospital Thessaloniki, Greece
  • Centre for Human Genetics Bangalore, India
  • Shaare Zedek Medical Center Jerusalem, Israel
View Trial Details
Completed

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT01207388

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • 1102 - LKH Graz Graz, Austria
  • 1107 - Krankenhaus der Elisabethinen Linz, Austria
  • 1106 Salzburg, Austria
  • 1101 - AKH Wien Vienna, Austria
View all 75 locations
View Trial Details

Related conditions